Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

We aimed to examine the mechanisms by which rosiglitazone improves glycaemic control in Type II (non-insulin-dependent) diabetic patients. Altogether 29 diet-treated diabetic patients were assigned at random to rosiglitazone, 8 mg/day (n = 15), or placebo (n = 14) for 12 weeks. Patients received 75...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetologia 2001-12, Vol.44 (12), p.2210-2219
Hauptverfasser:	MIYAZAKI, Y, GLASS, L, TRIPLITT, C, MATSUDA, M, CUSI, K, MAHANKALI, A, MAHANKALI, S, MANDARINO, L. J, DEFRONZO, R. A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Blood Glucose - analysis Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Double-Blind Method Fatty Acids, Nonesterified - blood General and cellular metabolism. Vitamins Glucose - biosynthesis Glucose Tolerance Test Humans Hypoglycemic Agents - therapeutic use Insulin - blood Medical sciences Middle Aged Osmolar Concentration Oxidation-Reduction Pharmacology. Drug treatments Regression Analysis Thiazoles - therapeutic use Thiazolidinediones
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!